Exclusive Interviews

In part 1 of this Exclusive Interview, Joshua Safer talks with Diabetes in Control Publisher Steve Freed about the need to understand the evidence for and approach to transgender medicine, and strategies for the use of hormones.

In part 2 of this Exclusive Interview, Joshua Safer talks with Diabetes in Control Publisher Steve Freed about working with transgender patients and the course of a conversation with a new patient.

In part 3 of this Exclusive Interview, Joshua Safer talks with Diabetes in Control Publisher Steve Freed about the number of specialists that can be found and more on the field overall as a specialty.

In part 4 of this Exclusive Interview, Joshua Safer talks with Diabetes in Control Publisher Steve Freed about the potential of hormones to cause diabetes.

Lisa Letourneau, MPH, RD, LDN, is a diabetes researcher, dietitian, and public health professional. As Diabetes and Genetics Clinical Research Manager at the University of Chicago, her work focuses on managing multiple studies related to atypical diabetes, including the largest monogenic diabetes registry in the United States.

In this Exclusive Interview transcript, Lisa Letourneau talks with Diabetes in Control publisher Steve Freed during the ADA 2018 convention in Orlando about genetics and diabetes, and how monogenic diabetes differs from type 1 and type 2.

In this Exclusive Interview, Lisa Letourneau talks with Diabetes in Control publisher Steve Freed during the ADA 2018 convention in Orlando about genetics and diabetes.

In part 1 of this Exclusive Interview, Lisa Letourneau talks with Diabetes in Control Publisher Steve Freed about distinguishing monogenic diabetes from other types of diabetes.

In part 2 of this Exclusive Interview, Lisa Letourneau talks with Diabetes in Control Publisher Steve Freed about the genetic diagnosis of monogenic diabetes and determining the proper treatment.

In part 3 of this Exclusive Interview, Lisa Letourneau talks with Diabetes in Control Publisher Steve Freed about the impact of monogenic diabetes on blood sugar levels, which may vary depending on the type of monogenic diabetes diagnosed and other patient-specific factors.